Anti-vaccine antibodies against measles, rubella, parotitis and hepatitis B in children with inflammatory bowel disease and healthy controls

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

289

Tables (1-2)

Sum=453

Publishing Process of This Article

Item

Count

Browse

Download

175

Sum=187

Sep 9, 2025 (publication date) through Jul 28, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Pediatrics

ISSN

2219-2808

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Clin Pediatr. Sep 9, 2025; 14(3): 104704
Published online Sep 9, 2025. doi: 10.5409/wjcp.v14.i3.104704

Table 2 Post-vaccine immunity in inflammatory bowel diseases patients and healthy peers, n (%)/median (25^th-75^th percentiles)

Parameter	IBD (n = 98)	Healthy (n = 88)	P value
Antibodies against measles, IgG, (IU/mL)	0.15 (0.0-0.35)	0.5 (0.0-0.9)	0.00005
Complete vaccination against measles¹	65 (66.3)	88 (100)	0.00001
Patients with a protective level of antibodies against measles	41/86 (47.7)	57 (58.2)	0.018
Antibodies against mumps, IgG, (IU/mL)	2.8 (0.9-5.0)	3.4 (1.2-7.2)	0.555
Complete vaccination against mumps¹	21 (21.4)	88 (100)	0.00001
Patients with a protective level of antibodies against mumps	64/88 (49.6)	65 (50.4)	0.765
Antibodies against rubella, (IU/mL)	32 (0.0-52.0)	200 (110.7-200)	0.0000001
Complete vaccination against rubella¹	25/97 (25.8)	88 (100)	0.00001
Patients with protective levels of antibodies against rubella	64/86 (74.4)	60/67 (89.6)	0.018
Antibodies against hepatitis B, (IU/mL)	0 (0.0-30.0)	120.9 (9.4-373.6)	0.0000001
Complete vaccination against hepatitis B¹	72/97 (74.2)	88 (100)	0.00001
Patients with protective levels of antibodies against hepatitis B	39/87 (44.8)	65 (73.9)	0.0001

¹According to the National vaccination schedule to the age.

IBD: Inflammatory bowel disease.

Citation: Makarova E, Goleva O, Gabrusskaya T, Ulanova N, Volkova N, Shilova E, Tolkmit M, Revnova M, Kharit S, Kostik M. Anti-vaccine antibodies against measles, rubella, parotitis and hepatitis B in children with inflammatory bowel disease and healthy controls. World J Clin Pediatr 2025; 14(3): 104704
URL: https://www.wjgnet.com/2219-2808/full/v14/i3/104704.htm
DOI: https://dx.doi.org/10.5409/wjcp.v14.i3.104704